Some RTKs that are frequently dysregulated in ccRCC include vascular endothelial growth factor receptor (VEGFR), c-Met, epidermal growth factor receptor (EGFR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene EGFR and nonpapillary renal cell carcinoma.